{
    "clinical_study": {
        "@rank": "60397", 
        "acronym": "BIO-OHS", 
        "arm_group": [
            {
                "arm_group_label": "[HCO3-] >= 27 mmol/L (Group 1)", 
                "arm_group_type": "Other", 
                "description": "All obese patients with plasmatic[HCO3-] >= 27 mmol/L will be addressed to a pneumologist. The pneumology investigations will establish(or not) the diagnosis of OHS"
            }, 
            {
                "arm_group_label": "[HCO3-]< 27mmol/L+pneumologist (Group 2)", 
                "arm_group_type": "Other", 
                "description": "Among obese patients with serum [HCO3-]< 27 mmol/L, 300 randomized patients will be addressed to a pneumologist. The pneumology investigations will refute(or not)the diagnosis of OHS."
            }, 
            {
                "arm_group_label": "[HCO3-]< 27 mmol/L (Group 3)", 
                "arm_group_type": "Other", 
                "description": "Obese patients with a [HCO3-]<27 mmol/L randomized to group 3 will receive usual medical follow-up (end of study)"
            }
        ], 
        "brief_summary": {
            "textblock": "Rationale of the \"BIO-OHS\" study (Prevalence of Obesity Hypoventilation Syndrome):\n\n      The overall prevalence of Obesity Hypoventilation Syndrome (OHS) has never been directly\n      assessed in the general population. Actually, this prevalence has been assessed in patients\n      referred to sleep clinics with a potential diagnosis of sleep-disordered breathing or in\n      patients already diagnosed with sleep apnea. The purpose of this study is to determine the\n      prevalence of Obesity Hypoventilation syndrome in obese patients referred to clinical\n      laboratories for regular follow-up medical analysis."
        }, 
        "brief_title": "Prevalence of Obesity Hypoventilation Syndrome", 
        "completion_date": {
            "#text": "November 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Obesity Hypoventilation Syndrome", 
        "condition_browse": {
            "mesh_term": [
                "Obesity", 
                "Obesity Hypoventilation Syndrome", 
                "Hypoventilation", 
                "Respiratory Insufficiency"
            ]
        }, 
        "detailed_description": {
            "textblock": "No additional description"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  18 years old ans more\n\n          -  BMI over 30 kg/M2\n\n          -  Stable state (respiratory, metabolic and cardio-vascular) for the last 2 months\n\n          -  Addressed to a clinical labs for a blood check-up whatever the prescription\n\n        Exclusion Criteria:\n\n          -  No social security\n\n          -  Non cooperative patient, as judged by the investigator"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "1000", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 16, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01903135", 
            "org_study_id": "13-AGIR-02", 
            "secondary_id": "2013-A00744-41"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "[HCO3-] >= 27 mmol/L (Group 1)", 
                    "[HCO3-]< 27mmol/L+pneumologist (Group 2)", 
                    "[HCO3-]< 27 mmol/L (Group 3)"
                ], 
                "description": "for specific measurement of plasmatic bicarbonate", 
                "intervention_name": "Blood test analysis in the clinical labs", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": [
                    "[HCO3-] >= 27 mmol/L (Group 1)", 
                    "[HCO3-]< 27mmol/L+pneumologist (Group 2)"
                ], 
                "description": "complete respiratory check-up: Arterial blood gases analysis, spirometry, anthropometry, polygraphy or polysomnography.\nMedical history, previous treatments.", 
                "intervention_name": "Pneumologist consult to establish the diagnosis of OHS", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Obesity Hypoventilation Syndrome", 
            "Prevalence", 
            "Bicarbonate"
        ], 
        "lastchanged_date": "March 27, 2014", 
        "location": [
            {
                "contact": {
                    "email": "nchouri.pneumosud@orange.fr", 
                    "last_name": "Nathalie Chrouri, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Echirolles", 
                        "country": "France"
                    }, 
                    "name": "Cabinet de Pneumologie Grenoble SUD"
                }, 
                "investigator": [
                    {
                        "last_name": "Nathalie Chouri, MD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Bruno Lepaulle, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Michel Jeanmart, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "guillaume.richalet@medibio.fr", 
                    "last_name": "Guillaume Richallet, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Echirolles", 
                        "country": "France"
                    }, 
                    "name": "Laboratoire MEDIBIO Les Cedres"
                }, 
                "investigator": {
                    "last_name": "Guillaume Richalet, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "JPepin@chu-grenoble.fr", 
                    "last_name": "Jean Louis Pepin, Prof"
                }, 
                "facility": {
                    "address": {
                        "city": "Grenoble", 
                        "country": "France"
                    }, 
                    "name": "H\u00f4pital Michallon, Laboratoire EFCR et Sommeil"
                }, 
                "investigator": [
                    {
                        "last_name": "Tamisier Renaud, MD-PhD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Jean Louis Pepin, MD- PhD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Sandrine Launois-Rollinat, MD-PhD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "drbrunolivier@hotmail.com", 
                    "last_name": "Olivier Brun, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Perpignan", 
                        "country": "France"
                    }, 
                    "name": "Cabinet de Pneumologie Perpignan"
                }, 
                "investigator": {
                    "last_name": "Olivier Brun, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "phschlouch@biopole66.fr", 
                    "last_name": "Philippe Schlouch, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Thuir", 
                        "country": "France"
                    }, 
                    "name": "Laboratoire d'analyses medicales de Thuir"
                }, 
                "investigator": {
                    "last_name": "Philippe Schlouch, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "3", 
        "official_title": "Prevalence of Obesity Hypoventilation Syndrome in Subjects With Obesity Referred to Clinical (Medical Analysis) Laboratories for Regular Follow-up", 
        "overall_contact": {
            "email": "j.borel@agiradom.com", 
            "last_name": "Jean Christian Borel, PhD"
        }, 
        "overall_contact_backup": {
            "email": "n.taleux@agiradom.com", 
            "last_name": "Nellie Taleux, PhD"
        }, 
        "overall_official": {
            "affiliation": "University Hospital, Grenoble", 
            "last_name": "Jean-Louis Pepin, Pr, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "OHS prevalence, validated by arterial blood gases analysis, will be assessed by the percentage of patients with OHS among all patients included in the study", 
            "measure": "Prevalence of Obesity Hypoventilation Syndrome (OHS) in obese subjects referred to clinical laboratories for regular blood test analysis.", 
            "safety_issue": "No", 
            "time_frame": "From date of inclusion until the end of the study currently planned (up to 2 years)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01903135"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "A ROC curve will determine if the threshold of 27 mmol/L has the best diagnostic value.\nDecision trees will show if the diagnostic value of plasmatic [HCO3-]could be optimized by a combination with other clinical parameters.", 
                "measure": "Sensitivity and specificity of plasmatic [HCO3-] to detect OHS", 
                "safety_issue": "No", 
                "time_frame": "From date of inclusion to the end of the study currently planned (2 years)"
            }, 
            {
                "description": "Prevalence will be estimated by the percentage and the confidence interval. Prevalences of metabolic and cardiovascular comorbidities among patients with OHS and without OHS will be compared by a KHI-2 test or Fisher Exact depends on the theorical number.", 
                "measure": "Prevalence of metabolic and cardiovascular comorbidities in patients with OHS", 
                "safety_issue": "No", 
                "time_frame": "From date of inclusion to the end of the study currently planned (2 years)"
            }, 
            {
                "description": "estimated by percentage", 
                "measure": "To determine which medical specialties referred patients with OHS to clinical labs", 
                "safety_issue": "No", 
                "time_frame": "From date of inclusion to the end of the study currently planned (2 years)"
            }, 
            {
                "description": "Cardiovascular, metabolic and respiratory events (measured by percentages in OHS group and non-OHS group) will be compared by logistic regressions.", 
                "measure": "Incidence of serious health events at 1 and 2-year follow-up", 
                "safety_issue": "No", 
                "time_frame": "From time of OHS diagnostic to 1 and 2-year follow-up"
            }
        ], 
        "source": "AGIR \u00e0 Dom", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "AGIR \u00e0 Dom", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}